Singapore News - As part of measures to ensure the affordability of cancer treatments following the introduction of the Cancer Drug List (CDL) on Thursday, premiums for Integrated Shield Plans (IPs) will remain unchanged for the next two years. This applies to all IP policyholders, whether... Read more at www.tnp.sg